Protocols
LYACAL
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma using Acalabrutinib
LYALEM
Treatment with Subcutaneous or Intravenous Alemtuzumab for Fludarabine-Refractory B-Chronic Lymphocytic Leukemia (B-CLL) or with Intravenous Alemtuzumab for Previously Untreated T-Prolymphocytic Leukemia (T-PLL)
(See under Non-Hodgkin Lymphoma)
Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) with Bendamustine
LYCLLBENDR
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma with Bendamustine and riTUXimab
LYCLLCHLR
Treatment of Chronic Lymphocytic Leukemia with Chlorambucil and riTUXimab
LYCLLCVPR
Treatment of relapsed Chronic Lymphocytic Leukemia using Cyclophosphamide, vinCRIStine, predniSONE and riTUXimab (CVP-R)
Treatment of Previously Untreated Chronic Lymphocytic Leukemia (CLL) with Bendamustine and riTUXimab
Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and riTUXimab
Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma using Zanubrutinib
(See under Non-Hodgkin Lymphoma)
LYFACAL
Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma using Acalabrutinib
LYFCR
Treatment of Chronic Lymphocytic Leukemia (CLL) or Prolymphocytic Leukemia with Fludarabine, Cyclophosphamide and riTUXimab
Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Using iBRUtinib
(See under Non-Hodgkin Lymphoma)
LYIBRU
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Using Ibrutinib
LYIDELAR
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Using Idelalisib and riTUXimab
Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma with oBINutuzumab and Chlorambucil
(See under Non-Hodgkin Lymphoma)
ULYVENETO
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Using Venetoclax
LYVENETOR
Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Using Venetoclax and riTUXimab
LYVENOB
Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma using Venetoclax and oBINutuzumab
Top
Hodgkin Lymphoma
LYABVD
Treatment of Hodgkin's disease with DOXOrubicin, Bleomycin, vinBLAStine and Dacarbazine
ULYAJBV (replaced by LYBV)
Treatment for Adjuvant Therapy Post-Autologous Stem Cell Transplant (ASCT) for Hodgkin Lymphoma Using Brentuximab Vedotin
LYAVDBV
Treatment of Previously Untreated, Stage IV Hodgkin Lymphoma with DOXOrubicin, vinBLAStine, Dacarbazine and Brentuximab Vedotin
LYBRENTUX
Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma with Brentuximab Vedotin
LYBV
Consolidation Therapy Post-Autologous Stem Cell Transplant (ASCT) for Hodgkin Lymphoma Using Brentuximab Vedotin
LYBVAVDBV
Treatment of Previously Untreated, Stage IV Hodgkin Lymphoma with Sequential Brentuximab Vedotin and DOXOrubicin, vinBLAStine and Dacarbazine in Patients 60 Years or Older
LYCVPPABO
Treatment of Hodgkin's Disease with Cyclophosphamide, vinBLAStine, Procarbazine and predniSONE
LYCYCLO
(See under Non-Hodgkin Lymphoma)
LYGVLD
Treatment of Relapsed or Refractory Hodgkin Lymphoma with Gemcitabine, Vinorelbine and DOXOrubicin Pegylated Liposomal
LYNIV
Treatment of Relapsed or Refractory Hodgkin Lymphoma Using Nivolumab Protocol
LYNIV4
Treatment of Relapsed or Refractory Hodgkin Lymphoma Using 4-Weekly Nivolumab
LYPEM
Treatment of Relapsed or Refractory Hodgkin Lymphoma using Pembrolizumab
LYPEM6
Treatment of Relapsed or Refractory Hodgkin Lymphoma Using 6-Weekly Pembrolizumab
LYBEND
Treatment of Non-Hodgkin Lymphoma with Bendamustine
LYBENDO (previously LYOBBEND)
Treatment of riTUXimab-refractory Follicular Lymphoma (FL) with oBINutuzumab in combination with Bendamustine
LYBENDR
Treatment of Non-Hodgkin Lymphoma with Bendamustine and riTUXimab
LYCHLOR
Therapy for Low Grade Lymphoma and Chronic Lymphocytic Leukemia Using Chlorambucil
LYCHLRR
Treatment of Indolent B-cell Lymphoma with Chlorambucil and riTUXimab
LYCHOP
Treatment of Lymphoma with DOXOrubicin, Cyclophosphamide, vinCRIStine and predniSONE
LYCHOPO
Treatment of riTUXimab-refractory Follicular Lymphoma with DOXOrubicin, Cyclophosphamide, vinCRIStine, predniSONE, and oBINutuzumab
LYCHOPR
Treatment of Lymphoma with DOXOrubicin, Cyclophosphamide, vinCRIStine, predniSONE and riTUXimab
LYCHOPRMTX
Central Nervous System Prophylaxis with High Dose Methotrexate, CHOP and RiTUXimab in Diffuse Large B-cell Lymphoma
LYCODOXMR
Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Cyclophosphamide, vinCRIStine, DOXOrubicin, Methotrexate, Leucovorin (CODOX-M) and riTUXimab
LYCVP
Treatment of Advanced indolent lymphoma using Cyclophosphamide, vinCRIStine and predniSONE
LYCVPO
Treatment of riTUXimab-refractory Follicular Lymphoma with Cyclophosphamide, vinCRIStine, predniSONE and oBINutuzumab
LYCVPR
Treatment of Advanced Indolent Lymphoma using Cyclophosphamide, vinCRIStine, predniSONE and riTUXimab (CVP-R)
LYCYCLO
Therapy of Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia or Multiple Myeloma Using Cyclophosphamide
LYDHAPR
Treatment of Lymphoma with Dexamethasone, Cytarabine, Platinum and riTUXimab
ULYEPCOR
Treatment of Lymphoma using Epcoritamab
LYEPOCHR
Treatment of Lymphoma with Dose-Adjusted Etoposide, DOXOrubicin, vinCRIStine, Cyclophosphamide, predniSONE and riTUXimab with Intrathecal Methotrexate
LYFLU
Treatment of Low-Grade Lymphoma or Chronic Lymphocytic Leukemia with Fludarabine
LYFLUDR
Treatment of Relapsed Indolent Lymphoma with Fludarabine and riTUXimab
LYGDP
Treatment of Lymphoma with Gemcitabine, Dexamethasone and Platinum
LYGDPO
Treatment of riTUXimab-refractory Follicular Lymphoma with Gemcitabine, Dexamethasone, Platinum and oBINutuzumab
LYGDPR
Treatment of Lymphoma with Gemcitabine, Dexamethasone and Platinum with riTUXimab
LYHDMRP
(See LYHDMRTEM protocol)
LYHDMRTEM
Treatment of Primary and Secondary CNS Lymphoma with High Dose Methotrexate, riTUXimab and temozolomide
LYHDMTXP
(deleted 01 Sep 2021)
LYHDMTXPRO
Central Nervous System Prophylaxis with High Dose Methotrexate in Diffuse Large B-Cell Lymphoma
LYHDMTXR
(deleted 01 Sep 2021)
LYIT
Treatment of Lymphoma using Intrathecal Methotrexate and Cytarabine
LYIVACR
Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Ifosfamide, Mesna, Etoposide, Cytarabine (IVAC) and riTUXimab
LYMIBRU
Treatment of Relapsed/Refractory Mantle-Cell Lymphoma Using iBRUtinib
LYOBBEND (see LYBENDO)
Treatment of riTUXimab-refractory Follicular Lymphoma (FL) with oBINutuzumab in combination with Bendamustine
Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Not Eligible for Transplant using Polatuzumab Vedotin, Bendamustine and riTUXimab
LYRICE
Treatment of Relapsed or Refractory Advanced Stage Aggressive B-Cell Non-Hodgkin’s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and riTUXimab
LYRITUX
Treatment of Lymphoma with single agent riTUXimab
LYRITZ
Palliative Therapy For Lymphoma Using Radioimmunotherapy: riTUXimab-Priming for Ibritumomab 90Y (ZEVALIN®)
LYRMTN
Maintenance riTUXimab for Indolent Lymphoma
LYTEM
Treatment of Relapsed CNS Lymphoma using Temozolomide
Treatment of Waldenström Macroglobulinemia or Lymphoplasmacytic Lymphoma (LPL) using Zanubrutinib
ULYZANU (see ULYWMZANU)
Treatment of Waldenström Macroglobulinemia or Lymphoplasmacytic Lymphoma (LPL) using Zanubrutinib
LYALIT
Treatment of Cutaneous T-cell Lymphoma (Mycosis Fungoides/Sézary Syndrome) with Alitretinoin
LYASPMEDEX
Treatment of Refractory or Relapsing Extranodal Natural Killer or T-Cell Lymphoma Using Pegaspargase, Methotrexate and Dexamethasone
LYCARTOP (deleted 01 Dec 2024)
LYCHPBV
Treatment of CD30-Positive Peripheral T-Cell Lymphoma (PTCL) with DOXOrubicin, Cyclophosphamide, predniSONE (CHP) and Brentuximab Vedotin
LYCTCLBV (deleted 01 Dec 2024)
LYGEMOXPEG
Treatment of Newly Diagnosed or Relapsed/Refractory Natural Killer or T-Cell Lymphoma using Gemcitabine, Oxaliplatin and Pegaspargase
LYMECHLOR
Topical Chlormethine in Cutaneous T-cell Lymphoma
LYMFBEX
Treatment of Cutaneous T-cell Lymphoma (Mycosis Fungoides/Sézary syndrome) with Bexarotene
LYMFECP
Treatment of Cutaneous T-cell Lymphoma (Sézary syndrome) with Extracorporeal Photopheresis
ULYMOGA
Treatment of Mycosis Fungoides and Sézary Syndrome with Mogamulizumab
LYPRA
Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) with Pralatrexate
ULYROMI
Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) with romiDEPsin
LYSMILE
Treatment of Natural Killer or T-Cell Lymphoma Using Dexamethasone, Methotrexate, Ifosfamide, Pegaspargase and Etoposide
LYVIPDRT
Treatment of Newly Diagnosed Nasal, Extranodal Natural Killer (NK) or T-cell lymphoma, using Concurrent Radiation and weekly CISplatin followed by Etoposide, Ifosfamide, CISplatin and Dexamethasone
Top
Refer to Myeloma section for other protocols.
LYDARCBDF
Treatment of Previously Untreated Light Chain Amyloidosis and Not Eligible for Stem Cell Transplant using Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone
Top
Others
HLHETCSPA
Treatment of Hemophagocytic Lymphohistiocytosis with Etoposide, Dexamethasone and cycloSPORINE
LYCDA
Treatment of Hairy Cell Leukemia with Cladribine
LYCSPA
Cyclosporine for cytopenias associated with lymphoproliferative disorder of large granular lymphocytes
LYPALL
Lymphoma Palliative Chemotherapy
Treatment of Multicentric Castleman’s Disease (MCD) Negative for Human Immunodeficiency Virus (HIV) and Human Herpes Virus – 8 (HHV-8) Using Siltuximab
MYBLDF
Treatment of Previously Untreated Multiple Myeloma and Not Eligible for Stem Cell Transplant Using Bortezomib, Lenalidomide and Dexamethasone
MYBLDPRE
Treatment of Multiple Myeloma using Lenalidomide, Bortezomib and Dexamethasone as Induction Pre-Stem Cell Transplant
MYBORMTN
Maintenance Therapy of Multiple Myeloma Using Bortezomib for Patients with the High-Risk Chromosome Abnormality
MYBORPRE
Treatment of Multiple Myeloma Using Bortezomib, Dexamethasone with or without Cyclophosphamide as Induction Pre-Stem Cell Transplant
MYBORREL
Treatment of Relapsed Multiple Myeloma Using Bortezomib, Dexamethasone with or without Cyclophosphamide
MYBSD
Treatment of Multiple Myeloma using Bortezomib, Selinexor, and Dexamethasone With or Without Cyclophosphamide
MYCARDEX
Therapy of Multiple Myeloma Using Carfilzomib and Dexamethasone With or Without Cyclophosphamide
MYCARLD
Therapy of Multiple Myeloma Using Carfilzomib, Lenalidomide with Dexamethasone
MYDARBD
Treatment of Relapsed and Refractory Multiple Myeloma with Daratumumab in Combination with Bortezomib and Dexamethasone With or Without Cyclophosphamide
MYDARCBDF
Treatment of Previously Untreated Multiple Myeloma and Not Eligible for Stem Cell Transplant using Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone
MYDARLD
Treatment of Relapsed and Refractory Multiple Myeloma with Daratumumab in Combination with Lenalidomide and Dexamethasone With or Without Cyclophosphamide
MYDARLDF
Treatment of Previously Untreated Multiple Myeloma and Not Eligible for Stem Cell Transplant using Daratumumab, Lenalidomide and Dexamethasone
MYHDC
Single dose cyclophosphamide priming therapy for multiple myeloma prior to autologous stem cell transplant
UMYISACARD
Therapy of Multiple Myeloma using Carfilzomib, Dexamethasone and Isatuximab with or without Cyclophosphamide
UMYISAPOMD
Therapy of Multiple Myeloma using Pomalidomide, Dexamethasone and Isatuximab with or without Cyclophosphamide
Treatment of Previously Untreated Multiple Myeloma and Not Eligible for Stem Cell Transplant Using Lenalidomide with Low-dose Dexamethasone
MYLDREL
Therapy of Relapsed Multiple Myeloma Using Lenalidomide with Dexamethasone
MYLENMTN
Maintenance Therapy of Multiple Myeloma Using Lenalidomide
MYMP
Treatment of Multiple Myeloma Using Melphalan and predniSONE
MYMPBOR
Treatment of Multiple Myeloma using Melphalan, Prednisone and Weekly Bortezomib with the Option of Substituting Cyclophosphamide for Melphalan
MYPAM
Treatment of Multiple Myeloma with Pamidronate
Therapy of Multiple Myeloma Using Pomalidomide with Dexamethasone
MYZOL
Treatment of Multiple Myeloma with Zoledronic Acid
